Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.4 - $31.47 $687,300 - $1.24 Million
39,500 Added 118.26%
72,900 $2.08 Million
Q2 2024

Aug 15, 2024

SELL
$18.84 - $24.94 $235,500 - $311,750
-12,500 Reduced 27.23%
33,400 $727,000
Q1 2024

May 07, 2024

BUY
$18.06 - $25.3 $828,953 - $1.16 Million
45,900 New
45,900 $1.02 Million
Q3 2023

Nov 14, 2023

SELL
$13.28 - $20.3 $7,968 - $12,180
-600 Reduced 5.5%
10,300 $173,000
Q2 2023

Aug 11, 2023

SELL
$11.66 - $26.0 $66,462 - $148,200
-5,700 Reduced 34.34%
10,900 $149,000
Q1 2023

May 16, 2023

BUY
$19.47 - $28.49 $15,576 - $22,792
800 Added 5.06%
16,600 $377,000
Q4 2022

Feb 14, 2023

SELL
$18.08 - $30.0 $406,799 - $675,000
-22,500 Reduced 58.75%
15,800 $371,000
Q3 2022

Nov 14, 2022

BUY
$22.51 - $34.32 $477,212 - $727,584
21,200 Added 123.98%
38,300 $999,000
Q2 2022

Aug 15, 2022

BUY
$16.0 - $45.99 $155,200 - $446,103
9,700 Added 131.08%
17,100 $375,000
Q1 2022

May 16, 2022

BUY
$33.17 - $46.98 $3,317 - $4,698
100 Added 1.37%
7,400 $332,000
Q4 2021

Feb 14, 2022

SELL
$39.06 - $67.58 $285,138 - $493,334
-7,300 Reduced 50.0%
7,300 $313,000
Q3 2021

Nov 15, 2021

BUY
$60.13 - $77.6 $348,754 - $450,079
5,800 Added 65.91%
14,600 $971,000
Q2 2021

Aug 11, 2021

BUY
$50.07 - $76.78 $95,133 - $145,882
1,900 Added 27.54%
8,800 $645,000
Q1 2021

May 17, 2021

BUY
$58.92 - $97.33 $406,548 - $671,577
6,900 New
6,900 $472,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $739M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.